Skip to Main Content

Paper Details

Randomized Trial of Osilodrostat for the Treatment of Cushing Disease.
J Clin Endocrinol Metab
29
2022
Author NameAffiliation
Peter J SnyderPerelman School of Medicine, University of Pennsylvania
  • 1 - 1

Datasets

Release 1.2